Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Lundbeck

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Lundbeck's 2013 CNS (central nervous system) sales performance.

Teva sheds R&D chief after new CEO takes the helm

Teva sheds R&D chief after new CEO takes the helm at Lundbeck - and shares in Teva closed up 5.3% in the wake of the announcement.

Esteve appoints Albert Esteve as chairman of the board of directors

Esteve appoints Albert Esteve as chairman of the board of directors Additionally, Staffan Schuberg will join as chief executive officer, effective January 2018, following more than 20 years’ experience from pharmaceutical companies such as Lundbeck, where he held the position of executive

Lundbeck and Otsuka start phase III for Rexulti in bipolar

Lundbeck and Otsuka start phase III for Rexulti in bipolar sales growth accelerate, with Lundbeck reporting turnover of the drug up 85% to $91m in the first half of the year. ... Abilify. Lundbeck and Otsuka are also evaluating the drug in a phase II trial involving patients with post-traumatic stress disorder

Axovant joins ever-growing Alzheimer’s failure club

Axovant joins ever-growing Alzheimer’s failure club 5-HT6 inhibitor Intepirdine followsin the footsteps of Lundbeck's idalopirdine. Axovant’s phase III trial of Alzheimer’s disease (AD) candidate intepirdine has ended in failure, an outcome that ... Intepirdine - a serotonin 5-HT6 inhibitor - failed

Teva offloads women's health unit in quickfire deals

Teva offloads women's health unit in quickfire deals Teva's chief executive Yitzhak Peterburg - who will be replaced in the coming months by Lundbeck's Kåre Schultz - said that the two deals means that the company has already exceeded

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics